The Australian Pancreatic Genome Initiative
Lead Institution
Garvan Institute of Medical Research, Australia
Program Description
The Australian Pancreatic Genome Initiative (APGI) is a global research enterprise of over 100 scientists, clinicians and allied health professionals involved in pancreatic cancer research and care. The APGI has mapped the genome of pancreatic cancer in a landmark effort as part of Australia’s contribution to the International Cancer Genome Consortium (ICGC) 25k project and Pan Cancer Analysis project. This fundamental understanding of the genetic underpinnings of Pancreatic Cancer will accelerate the evolution of pancreatic cancer care into the molecular age of oncology. The APGI’s world-class BioResource – biological samples coupled with comprehensive clinical and genomic data – is aiding research worldwide in ongoing discovery and development through quality research and strategic collaborations.
Program Team
Anthony Gill, Royal North Shore Hospital, Sydney
Lead Investigator
Nicola Waddell, QIMR Berghofer Medical Research Institute, Brisbane
Lead Investigator
John Pearson, QIMR Berghofer Medical Research Institute, Brisbane
Lead Investigator
Garvan Institute of Medical Research, Australia
Garvan Institute of Medical Research, Australia
Garvan Institute of Medical Research, Australia
Macarthur Cancer Therapy Centre, Australia
Bankstown Hospital, Australia
Royal North Shore Hospital, Australia
Funding Organisations
PanKind, The Australian Pancreatic Cancer Foundation
Sydney, Australia
pankind.org.au
Further Information
Program Website